BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1155244)

  • 1. Management of acute myocardial infarction. Pathophysiological considerations.
    Sobel BE
    Adv Cardiol; 1975; 15():99-110. PubMed ID: 1155244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of infarct size.
    Hood WB
    Cardiovasc Clin; 1975; 7(2):259-78. PubMed ID: 811357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of myocardial ischemic injury.
    Sobel BE
    Adv Cardiol; 1975; 15():86-98. PubMed ID: 1155243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on protection of the ischemic myocardium.
    Braunwald E; Maroko PR
    Trans Am Clin Climatol Assoc; 1973; 84():80-115. PubMed ID: 4729259
    [No Abstract]   [Full Text] [Related]  

  • 5. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of canine myocardial infarcts in relation to indices of oxygen demand: preservation of myocardial creatine kinase activity by vagal stimulation and propranolol.
    Sammel NL; Norris RM; Hughes CF; Johnson RN; Ashton NG; Elliott RL
    Cardiovasc Res; 1983 Jan; 17(1):50-60. PubMed ID: 6850717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new conceptual approach to the therapy of acute myocardial infarction.
    Forrester JS; Chatterjee K; Jobin G
    Adv Cardiol; 1975; 15():111-23. PubMed ID: 1155236
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Blockade and acute myocardial infarction.
    Lie KI; Fiolet JW
    Eur Heart J; 1983 Jul; 4 Suppl D():167-71. PubMed ID: 6137379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer concepts in the pathophysiology of ischemic heart disease.
    Kirk ES; Factor S; Sonnenblick EH
    G Ital Cardiol; 1984 Nov; 14(11):881-91. PubMed ID: 6526205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
    Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD
    J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
    Maroko PR; Braunwald E
    Acta Med Scand Suppl; 1976; 587():125-36. PubMed ID: 3095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol in acute myocardial infarction in man: effects of haemodynamics and myocardial oxygenation.
    Mueller H; Ayres SM
    Postgrad Med J; 1976; 52 Suppl 4():141-8. PubMed ID: 967769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue salvage in acute myocardial infarction.
    Ross J
    Am J Surg; 1979 Sep; 138(3):392-7. PubMed ID: 112876
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors influencing infarct size following coronary artery occlusion.
    Kjekshus JK
    J Oslo City Hosp; 1974; 24(11-12):155-75. PubMed ID: 4615137
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic monitoring in acute myocardial infarction.
    Cairns JA
    Can Med Assoc J; 1979 Oct; 121(7):905-10. PubMed ID: 497981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Definition and significance of the area at risk in myocardial infarct and the ischemic border zone in acute myocardial infarct].
    Glogar DH
    Acta Med Austriaca Suppl; 1986; 36():1-40. PubMed ID: 3475927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction.
    Mueller H; Ayres SM; Conklin EF; Giannelli S; Mazzara JT; Grace WT; Nealon TF
    J Clin Invest; 1971 Sep; 50(9):1885-900. PubMed ID: 5564396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolism of the ischemic myocardium--clinical aspects].
    Kübler W
    Z Kardiol; 1984; 73 Suppl 2():107-12. PubMed ID: 6528696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical interventions for the preservation of ischemic myocardium.
    Rackley CE; Russell RO; Rogers WJ; Mantle JA; McDaniel HG; Reddy WJ
    Cardiovasc Clin; 1981; 11(3):163-77. PubMed ID: 7011554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.